Today

Agents

Chat

Arena

Discover

More

App

Pacific Biosciences of California Q2 EPS USD -0.14 - PACB News | Rallies

Pacific Biosciences of California Q2 EPS USD -0.14

PACB•2026-08-05

Q2 results

Aug. 05 (Reuters) - Pacific Biosciences of California Q2 adjusted gross margin 36%.

Q2 revenue USD 39 million vs. IBES estimate USD 40.1 million
Q2 adjusted gross profit USD 13.9 million
Q2 adjusted net income USD -41.9 million vs. IBES estimate USD -39.2 million
Q2 adjusted EPS USD -0.14 vs. IBES estimate USD -0.13

Related News

FalconStor Q2 revenue rises, net loss narrows on hybrid cloud offerings, operational streamlining

FALC•2026-08-05

Canada's Gold Royalty Q2 revenue rises 76% yr/yr

GROY•2026-08-05

Excelerate Energy Q2 FY26 net income rises 141% to $50.1 million; revenue climbs 61% to $329.3 million

EE

•

2026-08-05

Heritage Insurance Q2 net income rises 29%

HRTG•2026-08-05

Dolby SVP Entertainment John D. Couling disposes of 7,667 common shares for $460,454.42

DLB•2026-08-05